Role of Glucose-Lowering Medications in Erectile Dysfunction
Open Access
- 5 June 2021
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (11), 2501
- https://doi.org/10.3390/jcm10112501
Abstract
Erectile dysfunction (ED) is a long-term complication of type 2 diabetes (T2D) widely known to affect the quality of life. Several aspects of altered metabolism in individuals with T2D may help to compromise the penile vasculature structure and functions, thus exacerbating the imbalance between smooth muscle contractility and relaxation. Among these, advanced glycation end-products and reactive oxygen species derived from a hyperglycaemic state are known to accelerate endothelial dysfunction by lowering nitric oxide bioavailability, the essential stimulus of relaxation. Although several studies have explained the pathogenetic mechanisms involved in the generation of erectile failure, few studies to date have described the efficacy of glucose-lowering medications in the restoration of normal sexual activity. Herein, we will present current knowledge about the main starters of the pathophysiology of diabetic ED and explore the role of different anti-diabetes therapies in the potential remission of ED, highlighting specific pathways whose activation or inhibition could be fundamental for sexual care in a diabetes setting.This publication has 182 references indexed in Scilit:
- Interdisciplinary European Guidelines on Metabolic and Bariatric SurgeryObesity Facts, 2013
- Role for Substance P–Based Nociceptive Signaling in Progenitor Cell Activation and Angiogenesis During Ischemia in Mice and in Human SubjectsCirculation, 2012
- Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide: IUPHAR Review 1British Journal of Pharmacology, 2012
- Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension studyDiabetes, Obesity and Metabolism, 2011
- Effect of Intensive Glycemic Therapy on Erectile Function in Men With Type 1 DiabetesJournal of Urology, 2011
- Metformin Activates AMP Kinase through Inhibition of AMP DeaminaseOnline Journal of Public Health Informatics, 2011
- Erectile Dysfunction in Young Non-Obese Type II Diabetic Goto-Kakizaki Rats is Associated with Decreased eNOS Phosphorylation at Ser1177The Journal of Sexual Medicine, 2010
- Role of Adenosine Signaling in Penile Erection and Erectile DisordersThe Journal of Sexual Medicine, 2010
- Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative studyCardiovascular Diabetology, 2010
- Testosterone and Erectile Function: From Basic Research to a New Clinical Paradigm for Managing Men with Androgen Insufficiency and Erectile DysfunctionEuropean Urology, 2007